Cases reported "Coronary Restenosis"

Filter by keywords:



Filtering documents. Please wait...

1/29. Use of the multifunction probing catheter as an adjunctive device for occluded vein graft intervention.

    We describe the use of the multifunction probing catheter (Schneider, Bulach, switzerland) as an adjunct to conventional techniques in the treatment of a recent vein graft occlusion by thrombus, in order to highlight a possible further use for this device.
- - - - - - - - - -
ranking = 1
keywords = vein
(Clic here for more details about this article)

2/29. Acute profound thrombocytopenia following angioplasty: the dilemma in the management and a review of the literature.

    Abciximab, heparin, and clopidogrel are often used together in the setting of coronary syndromes. These drugs are associated with thrombocytopenia and it is important to quickly discriminate the cause of this complication as it has implications for the management of thrombocytopenia and the coronary syndrome. This case highlights some of the dilemmas that may arise as no test can definitively identify the offending drug, and stopping these drugs can affect the outcome of the coronary event including stent thrombosis.
- - - - - - - - - -
ranking = 74.936334999475
keywords = thrombosis
(Clic here for more details about this article)

3/29. Successful long-term therapy following saphenous vein-covered stent deployment for atherosclerotic coronary aneurysm.

    We describe a case of atherosclerotic aneurysm involving the left main coronary artery in a patient with prior coronary artery bypass surgery. A saphenous vein-covered stent was used to seal the aneurysm in conjunction with conventional stenting of an associated native vessel coronary stenosis. Focal late restenosis involving the stent graft was successfully treated with repeat angioplasty and brachytherapy. Autologous vein-covered stent deployment should be considered in the treatment of symptomatic or progressively enlarging coronary aneurysms.
- - - - - - - - - -
ranking = 1.2
keywords = vein
(Clic here for more details about this article)

4/29. Cardiac manifestations of the antiphospholipid antibody syndrome: a review.

    The antiphospholipid antibody syndrome (APLAS), though an uncommon entity involves multiple organs in the body. The antiphospholipid antibodies (APLA) refer to several groups of autoantibodies against negatively charged phospholipids occurring independently or in association with systemic lupus erythematosus (SLE) and related autoimmune disorders. Several studies to date found those patients with APLA, predominantly IgG and to lesser extent IgM isotype and lupus anticoagulant (LAC) are associated with arterial and venous thrombosis, recurrent fetal loss, thrombocytopenia, and livedo reticularis. We have described two cases of APLAS, one primary and the other secondary, their management and cardiac manifestations. Cardiac manifestations of the syndrome include coronary artery thrombosis and valvular heart disease. These can be serious and difficult to treat. Although the exact treatment of the cardiac manifestations of APLAS is not clear, anticoagulation is the currently recommended therapy.
- - - - - - - - - -
ranking = 149.87266999895
keywords = thrombosis
(Clic here for more details about this article)

5/29. natural history of inadvertent aorta-saphenous vein-coronary vein bypass graft.

    Inadvertent distal anastomosis of an aortocoronary bypass graft to a coronary vein is a rare but potentially serious complication of coronary artery bypass surgery. We describe a patient in whom such a conduit was discovered only incidentally 17 years after its creation. This case illustrates the pertinent features of this anomaly and demonstrates that it can have a benign natural history.
- - - - - - - - - -
ranking = 1.8
keywords = vein
(Clic here for more details about this article)

6/29. Late thrombosis after gamma-brachytherapy.

    Late stent thrombosis (> 30 days after treatment) is a new phenomenon occurring after vascular brachytherapy. We report the analysis of 11 patients with late thrombosis after gamma-irradiation treatment of in-stent restenosis. All patients had in-stent restenosis and angina. Contributing factors to late thrombosis include long stents, small distal vessels, and complex lesion morphology.
- - - - - - - - - -
ranking = 524.55434499633
keywords = thrombosis
(Clic here for more details about this article)

7/29. Acute stent thrombosis after early withdrawal of platelet glycoprotein IIb/IIIa antagonists: potential rebound prothrombotic effect?

    We report on two cases of acute coronary stent thrombosis after early withdrawal of different competitive inhibitors of the platelet glycoprotein IIb/IIIa receptor, eptifibatide and tirofiban. Differences in pharmacokinetics between different types of glycoprotein IIb/IIIa receptor blockers and a potential rebound prothrombotic effect with the use of these antiplatelet drugs are reviewed.
- - - - - - - - - -
ranking = 374.68167499738
keywords = thrombosis
(Clic here for more details about this article)

8/29. Mechanisms and methods to resolve edge effect.

    Vascular brachytherapy (VBT) has established itself as a viable modality to treat in-stent restenosis (ISR). The problems associated with VBT have been understood well and remedied. Late thrombosis has been overcome to a great extent by prolonged antiplatelet therapy. Edge effect is another important limitation of VBT and is due to inadequate radiation coverage of the edges following VBT. It may be overcome by confining injury to the lesion segment and extending the radiation sources by a few millimeters from the injured segment.
- - - - - - - - - -
ranking = 74.936334999475
keywords = thrombosis
(Clic here for more details about this article)

9/29. Myocardial perfusion during transient slow-flow in the patient with old vein graft intervention: assessment by serial measurement of pressure-derived fractional flow reserve and thermodilution-derived coronary flow reserve.

    A patient with distal slow-flow after stenting in the old vein graft intervention was reported. This case is a first in whom guidewire-based serial measurement of pressure-derived fractional flow reserve (FFR(myo)) and thermodilution-based coronary flow reserve (CFR(thermo)) clearly demonstrated the serial change of microvascular circulation. During slow-flow, CFR(thermo) remained in low value despite significant improvement of FFR(myo) from 0.61 to 0.90. After thrombus aspiration and nicorandil injection, coronary flow reestablished immediately. CFR(thermo) improved significantly from 1.3 during slow-flow to 3.6 after restoration of flow.
- - - - - - - - - -
ranking = 1
keywords = vein
(Clic here for more details about this article)

10/29. Treatment of long, diffuse in-stent restenosis with sirolimus-eluting stents.

    Treatment of long, diffuse in-stent restenosis remains a therapeutic challenge. We report the successful use of multiple sirolimus-eluting stents (three 33-mm long stents) in a long, diffuse in-stent restenotic lesion. No major adverse cardiovascular events, including acute/subacute/delayed stent thrombosis, were noted at ten months. angiography at six months showed widely patent stents with 19% restenosis only at the worst segment.
- - - - - - - - - -
ranking = 74.936334999475
keywords = thrombosis
(Clic here for more details about this article)
| Next ->


Leave a message about 'Coronary Restenosis'


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.